Cargando…

Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α(2)-adrenoceptors and 5-HT(1) receptors

BACKGROUND: Dihydroergotamine (DHE) is an antimigraine drug that produces cranial vasoconstriction and inhibits trigeminal CGRP release; furthermore, it inhibits the vasodepressor sensory CGRPergic outflow, but the receptors involved remain unknown. Prejunctional activation of α(2A/2C)-adrenergic, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Hernández, Abimael, Lozano-Cuenca, Jair, Marichal-Cancino, Bruno A., MaassenVanDenBrink, Antoinette, Villalón, Carlos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970131/ https://www.ncbi.nlm.nih.gov/pubmed/29802544 http://dx.doi.org/10.1186/s10194-018-0869-8

Ejemplares similares

Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms
por: González-Hernández, Abimael, et al.
Publicado: (2023)

Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats
por: Miguel-Martínez, Alejandro D., et al.
Publicado: (2023)

Monoaminergic Receptors as Modulators of the Perivascular Sympathetic and Sensory CGRPergic Outflows
por: Marichal-Cancino, Bruno A., et al.
Publicado: (2020)

The role of α(1)- and α(2)-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2017)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases
por: González-Hernández, Abimael, et al.
Publicado: (2016)

Inhibition of prejunctional parasympathetic pathways by β(3)-adrenoceptor agonists in the isolated pig detrusor: comparison with human detrusor studies
por: D’Agostino, Gianluigi, et al.
Publicado: (2023)

The differential in vivo contribution of spinal α(2A)- and α(2C)-adrenoceptors in tonic and acute evoked nociception in the rat
por: López-Córdoba, Gustavo, et al.
Publicado: (2022)

Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries
por: Gupta, Saurabh, et al.
Publicado: (2007)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients
por: Hasegawa, Misaki, et al.
Publicado: (2021)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
por: Kori, S, et al.
Publicado: (2013)

Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Prejunctional and postjunctional actions of heptanol and 18β-glycyrretinic acid in the rodent vas deferens
por: Rahman, Faisal, et al.
Publicado: (2009)

Vasodepressor Effects of Adenosine in the Cat are Independent of Cyclooxygenase, Potassium Channels, and Nitric Oxide Pathways
por: Kaye, Alan David, et al.
Publicado: (2019)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Dihydroergotamine (DHE) – Then and Now: A Narrative Review
por: Silberstein, Stephen D., et al.
Publicado: (2019)

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT(1F) receptor agonist lasmiditan
por: Rubio‐Beltrán, Eloísa, et al.
Publicado: (2019)

Influence of varying estrogen levels on trigeminal CGRP release in healthy women
por: Ibrahimi, K, et al.
Publicado: (2013)

Protective effects of PACAP in ischemia
por: Reglodi, Dora, et al.
Publicado: (2018)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Evaluation of a Monthly Coverage Maximum (Drug-Specific Quantity Limit) on the 5-HT1 Agonists (Triptans) and Dihydroergotamine Nasal Spray
por: Hoffman, Lauren, et al.
Publicado: (2003)

Differential Mechanisms of Ang (1-7)-Mediated Vasodepressor Effect in Adult and Aged Candesartan-Treated Rats
por: Bosnyak, S., et al.
Publicado: (2012)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Could erectile dysfunction be a side effect of CGRP inhibition? A case report
por: Al-Hassany, Linda, et al.
Publicado: (2021)

Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache
por: Robbins, Nathaniel M., et al.
Publicado: (2016)

Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus
por: Mullaguri, Naresh, et al.
Publicado: (2018)

Characterization of Prejunctional Muscarinic Receptors: Effects on the Release of VIP and Functional Responses and Receptor Expression in the Ovine Submandibular Gland
por: Ryberg, Anders T., et al.
Publicado: (2009)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat
por: Tfelt-Hansen, Peer, et al.
Publicado: (2007)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives
por: DELGERMURUN, Dugar, et al.
Publicado: (2015)

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nk72vdpk9fns440movrstrsgvv